New data will be presented about Precise® Molecular Residual Disease (MRD) Test and MyRisk® Hereditary Cancer Test ...

Friedreich's ataxia (FA) is a rare but devastating genetic disorder. Those with the condition are often diagnosed between 5 ...

Shares of genetic testing company Myriad Genetics (NASDAQ:MYGN) jumped 2.5% in the afternoon session after the company ...

A genetic variant is likely putting some children suffering with myocarditis - inflammation of the heart muscle - at higher risk of developing heart failure, which can be fatal, according to a study ...

Researchers have captured the first detailed molecular snapshots of human polynucleotide phosphorylase (hPNPase) in action, ...

A genetic variant is likely putting some children suffering with myocarditis—inflammation of the heart muscle—at higher risk ...

A 46-year-old man with advanced lung cancer recovered after doctors used Next Generation Sequencing to identify a rare ALK fusion mutation and treat him with targeted therapy instead of chemotherapy.

India’s pioneering clinical geneticist, Dr. Annie Q. Hasan, breaks down how genes shape health, disease, and daily medical ...

Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...

Scientists have uncovered a surprising genetic workaround that helps cells cope with Friedreich’s ataxia, a rare and devastating disorder.

*The Co-Dx PCR platform (including the Co-Dx PCR Home (TM), Co-Dx PCR Pro (TM), mobile app, and all associated tests and software) is subject to review by the FDA and/or other regulatory bodies and is ...

The point-of-care (POC) molecular diagnostics market is steadily expanding, with a compound annual growth rate (CAGR) of approximately 6%. This growth is fueled by a growing need for fast, ...